MedTrace Logo

Sinopsys® Lacrimal Stent Indicated for Sinus Irrigation

NCT03304951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-09-06

No results posted yet for this study

Summary

The primary objective is to evaluate clinical data related to the safety and performance of the Sinopsys® Lacrimal Stent.

Conditions

  • Ethmoid Sinusitis

Interventions

DEVICE

Sinopsys® Lacrimal Stent

The Sinopsys® Lacrimal Stent is indicated for use in creating a transcaruncular ethmoid access.

Sponsors & Collaborators

  • Sinopsys Surgical

    lead INDUSTRY

Principal Investigators

  • Vladan Hrabe, MD · Charles University, Pilsen Czech Republic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03304951 on ClinicalTrials.gov